$BFLY

Butterfly Network (BFLY) officer to sell 140K shares

Butterfly Network officer Steven Cashman filed a notice to sell 140,112 Class A shares, worth approximately $1.0M, including shares to cover tax obligations on vested equity. The sale will be conducted through Fidelity Brokerage Services LLC.

Original reporting
Published Sep 4, 2026, 7:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 5, 2026, 2:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$BFLY
Bearish
medium confidence
Mentioned
$BFLY
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$BFLYBearishLow
01

Why it matters

The filing provides fresh data on insider holdings and may influence short-term trading sentiment.

02

Market read

New insider sale filing for BFLY, modest size, may cause slight price dip.

03

What to watch

Potential tax-driven liquidation rather than lack of confidence in the business.

Relevance 5/10Novelty 6/10Timing: same day filing

Background

Form 144 filings disclose planned sales of restricted securities by insiders, often used to meet tax obligations.

Company-level read

Ticker impact

$BFLYBearishMedium confidence
Context

Officer Steven Cashman filed a Form 144 to sell 140,112 Class A shares, a new insider sale filing.

Expected impact

Modest downward pressure on BFLY price in the near term.

Evidence & confidence

The sale represents a $1M disposition by an insider, indicating possible liquidity need, but the amount is modest relative to market cap.

Market effects

Minimal impact on the broader medical imaging sector.

Limited to U.S. investors tracking insider activity.

Low

Counterpoint

The insider sale may be routine and not indicative of company fundamentals.

Key entities

  • Steven Cashman

    Officer at Butterfly Network filing the sale.

Related articles

$BFLYHighAI 8/10

Why is Butterfly Network stock surging today?

Butterfly Network (BFLY) stock rose 11.5% after Needham initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and Embedded business model. TD Cowen also has a Buy rating and $10 target. BFLY's Q3 revenue grew 39% YoY, with Embedded segment growth and expanding margins. The broader market had minimal impact on BFLY's surge.

$BFLYMed

Butterfly Network at Morgan Stanley conference: platform push widens reach

Butterfly Network (BFLY) presented its strategy at Morgan Stanley's conference, shifting from handheld ultrasound to a semiconductor imaging platform. The company reported 20% revenue growth, with $112M in last 12-month revenue, and highlighted partnerships like Midjourney. It aims to expand its addressable market to $250B through its Butterfly Embedded model. The company expects a fourth-generation chip in 2027 to improve image quality and challenge competitors. Management emphasized its strong

$BFLYMed

Butterfly Network (BFLY) Is Up 24.2% After Raising 2026 Guidance And Narrowing Losses - Has The Bull Case Changed?

Butterfly Network (BFLY) shares rose 24.2% after the company reported Q2 2026 revenue of $32.61M and a reduced net loss of $12.91M, and raised 2026 revenue guidance to $119M to $123M. The article cites improving losses and momentum in Embedded partnerships and enterprise point-of-care ultrasound, while noting ongoing cash burn and potential dilution risks.

$BFLYMedAI 9/10

Butterfly (BFLY) Q2 2026 Earnings Call Transcript

Butterfly Network (BFLY) reported Q2 2026 revenue of $32.6M, up 39% y/y, driven by Embedded revenue of $10.8M (+439%). Gross profit rose to $23.3M and gross margin to 71%. Adjusted EBITDA loss narrowed to $1.4M. Q3 revenue guidance is $26M to $30M, and FY2026 revenue guidance is $119M to $123M.

$BFLYMedAI 8/10

Butterfly Network, Inc. Q2 2026 Earnings Call Summary

Butterfly Network, Inc. reported Q2 2026 progress driven by POCUS, Home and Community Care, and Embedded partnerships. Embedded revenue rose 439% on the Midjourney partnership. Gross margin was 71%. Full-year 2026 revenue guidance was raised to $119 million-$123 million. Home and Community Care first commercial implementation starts Oct 1, with revenue in Q4 2026.